<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39365483</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>169</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Comparative study of the propagation and plaque titration conditions for human coronavirus OC43 as a surrogate for SARS-CoV-2.</ArticleTitle><Pagination><StartPage>214</StartPage><MedlinePgn>214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-024-06146-9</ELocationID><Abstract><AbstractText>The ongoing COVID-19 pandemic is threatening human health globally. The development of effective drugs and vaccines against SARS-CoV-2 is hindered by the limited access to high-biosafety-level facilities. Although human coronavirus (HCoV) OC43, a low-pathogenic endemic human coronavirus, has been used as a surrogate virus for SARS-CoV-2 research, a standard technique for HCoV-OC43 culture and plaque titration has not been established. Our objective was to establish optimized culture and titration protocols for HCoV-OC43. The growth kinetics and permissibility to HCoV-OC43 infection of seven different cell lines were examined concurrently at two different temperatures, 33°C and 37°C. Cell lines exhibiting a cytopathic effect (CPE) were selected for plaque titration. No significant difference in the rate of cell growth was observed at the two temperatures tested. Interestingly, HCoV-OC43 was found not to be a high-temperature-sensitive virus, since it grew well at 37°C. Although RD, LLC-MK2, MRC-5, and HCT-8 cell lines supported virus growth with an obvious cytopathic effect and a high yield of virus after two days of infection, only RD cells were suitable for producing countable plaques. The incubation of the cells with 1.2% low-viscosity Avicel as an overlay medium at 37°C for 4 days appeared to promote clearer and sharper plaque morphology. However, further optimization of the plaque titration protocol is still required due to the continued observation of plaque size variation and hazy zones. We propose a cost-effective protocol for HCoV-OC43 culture and plaque titration that can be implemented at a standard conventional temperature without the need for additional special equipment.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niyomdecha</LastName><ForeName>Nattamon</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-5364-6716</Identifier><AffiliationInfo><Affiliation>Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Rangsit Campus, Pathum Thani, 12120, Thailand. nattamon@tu.ac.th.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonarkart</LastName><ForeName>Chompunuch</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thongon</LastName><ForeName>Songkran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auewarakul</LastName><ForeName>Prasert</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AHSRS 1/2566</GrantID><Agency>Thammasat University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028962" MajorTopicYN="Y">Coronavirus OC43, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="Y">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="Y">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014776" MajorTopicYN="N">Virus Cultivation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365483</ArticleId><ArticleId IdType="doi">10.1007/s00705-024-06146-9</ArticleId><ArticleId IdType="pii">10.1007/s00705-024-06146-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Savoie C, Lippé R (2022) Optimizing human coronavirus OC43 growth and titration. PeerJ 10:e13721. https://doi.org/10.7717/peerj.13721</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.13721</ArticleId><ArticleId IdType="pubmed">35833016</ArticleId><ArticleId IdType="pmc">9272819</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirtzinger EE, Kim Y, Davis AS (2022) Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2. J Virol Methods 299:114317. https://doi.org/10.1016/j.jviromet.2021.114317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114317</ArticleId><ArticleId IdType="pubmed">34634321</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty A, Diwan A (2020) NL63: A better surrogate virus for studying SARS-CoV-2. Integr Mol Med 8:1–9. https://doi.org/10.15761/IMM.1000408</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/IMM.1000408</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395(10224):565–574. https://doi.org/10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId><ArticleId IdType="pmc">7159086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Ma C, Szeto T, Hurst B, Tarbet B, Wang J (2020) Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture. ACS Infect Dis 7(3):586–597. https://doi.org/10.1021/acsinfecdis.0c00761</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Meng X, Zhang F, Xiang Y, Wang J (2021) The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect 10(1):317–330. https://doi.org/10.1080/22221751.2021.1888660</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1888660</ArticleId><ArticleId IdType="pubmed">33560940</ArticleId><ArticleId IdType="pmc">7919907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert F, Jacomy H, Marceau G, Talbot PJ (2008) Titration of human coronaviruses, HcoV-229E and HCoV-OC43, by an indirect immunoperoxidase assay. Methods Mol Biol 454:93–102. https://doi.org/10.1007/978-1-59745-181-9_8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-59745-181-9_8</ArticleId><ArticleId IdType="pubmed">19057861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracci N, Pan HC, Lehman C, Kehn-Hall K, Lin SC (2020) Improved plaque assay for human coronaviruses 229E and OC43. PeerJ 8:e10639. https://doi.org/10.7717/peerj.10639</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.10639</ArticleId><ArticleId IdType="pubmed">33391888</ArticleId><ArticleId IdType="pmc">7759117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruckova M, McIntosh K, Kapikian AZ, Kehn-Hall K, Lin SC (1970) The adaptation of two human coronavirus strains (OC38 and OC43) to growth in cell monolayers. Proc Soc Exp Biol Med 135(2):431–435. https://doi.org/10.3181/00379727-135-35068</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-135-35068</ArticleId><ArticleId IdType="pubmed">4991398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose R, Watanabe N, Bandou R, Yoshida T, Daidoji T, Naito Y et al (2021) A cytopathic effect-based tissue culture method for HCoV-OC43 titration using TMPRSS2-expressing VeroE6 cells. mSphere 6(3):e00159–e00121. https://doi.org/10.1128/mSphere.00159-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00159-21</ArticleId><ArticleId IdType="pubmed">33980675</ArticleId><ArticleId IdType="pmc">8125049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DE, Min JS, Jang MS, Lee JY, Shin YS, Song JH et al (2019) Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules 9(11):696. https://doi.org/10.3390/biom9110696</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9110696</ArticleId><ArticleId IdType="pubmed">31690059</ArticleId><ArticleId IdType="pmc">6921063</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt OW, Cooney MK, Kenny GE (1979) Plaque assay and improved yield of human coronaviruses in a human rhabdomyosarcoma cell line. J Clin Microbiol 9(6):722–728. https://doi.org/10.1128/jcm.9.6.722-728.1979</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.9.6.722-728.1979</ArticleId><ArticleId IdType="pubmed">500803</ArticleId><ArticleId IdType="pmc">275387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Ma C, Wang J (2022) Cytopathic effect assay and plaque assay to evaluate in vitro activity of antiviral compounds against human coronaviruses 229E, OC43, and NL63. Bio Protoc 12(3):e4314. https://doi.org/10.21769/BioProtoc.4314</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.4314</ArticleId><ArticleId IdType="pubmed">35284599</ArticleId><ArticleId IdType="pmc">8855088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Z, Zhang Y, He Z, Liu J, Lan K, Hu Y et al (2016) A melting curve-based multiplex RT-qPCR assay for simultaneous detection of four human coronaviruses. Int J Mol Sci 17(11):880. https://doi.org/10.3390/ijms17111880</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17111880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MI, Lee C (2023) Human coronavirus OC43 as a low-risk model to study COVID-19. Viruses 15(2):578. https://doi.org/10.3390/v15020578</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020578</ArticleId><ArticleId IdType="pubmed">36851792</ArticleId><ArticleId IdType="pmc">9965565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulswit RJG, Lang Y, Bakkers MJG, Li W, Li Z, Schouten A et al (2019) Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc Natl Acad Sci U S A 116(7):2681–2690. https://doi.org/10.1073/pnas.1809667116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809667116</ArticleId><ArticleId IdType="pubmed">30679277</ArticleId><ArticleId IdType="pmc">6377473</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi M, Lee WS, Chan WOY, He W, Mah MG, Yong CL et al (2023) Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor. Emerg Microbes Infect 12(2):2256416. https://doi.org/10.1080/22221751.2023.2256416</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2256416</ArticleId><ArticleId IdType="pubmed">37672505</ArticleId><ArticleId IdType="pmc">10512916</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer A, Kehn-Hall K (2014) Viral concentration determination through plaque assays: Using traditional and novel overlay systems. JoVE 4(93):e52065. https://doi.org/10.3791/52065</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52065</ArticleId></ArticleIdList></Reference><Reference><Citation>Smither SJ, Lear-Rooney C, Biggins J, Pettitt J, Lever MS, Olinger GG Jr (2013) Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. J Virol Methods 193(2):565–571. https://doi.org/10.1016/j.jviromet.2013.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2013.05.015</ArticleId><ArticleId IdType="pubmed">23748121</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>